Valeant Pharmaceuticals to Announce 2009 Fourth Quarter and Year Resu…ALISO VIEJO, Calif., Feb. 8 /PRNewswire-FirstCall/ -- Valeant Pharmaceutica... |
FDA Accepts NDA Filing for RetigabineMAA successfully validated by EMEA ALISO VIEJO, Calif., Dec. 30 /PRNewswire... |
Critical Alerts for AIG, Baidu.com, PPG, Jefferies Group, and Valeant…CHICAGO, Nov. 24 /PRNewswire/ -- Seven Summits Research issues PriceWatch... |
Valeant Pharmaceuticals Highlights Taribavirin Phase IIb End of Study…ALISO VIEJO, Calif., Nov. 3 /PRNewswire-FirstCall/ -- Valeant Pharmaceutica... |
Valeant Pharmaceuticals Reports Third Quarter Financial Results- Revenue up 31%, 45% at constant exchange rates - GAAP EPS $0.45, Cash EPS... |
Valeant to Acquire Major Australian Skincare Brands-- Dr. LeWinn's is the highest selling skincare brand in Australian... |
Valeant Provides Update on Retigabine-- U.S. submission expected on or before October 23, 2009 -- EMEA submission... |
Valeant Pharmaceuticals to Present at the UBS Global Life Sciences Co…ALISO VIEJO, Calif., Sept. 17 /PRNewswire-FirstCall/ -- Valeant... |
MultiVu Video Feed: LONNIE ALI CHAMPIONS "FIGHT FOR MORE" CAMPAIGNWife of Muhammad Ali Joins New Educational Campaign Supporting Parkinson's... |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions